Information Technology, Improved Access, and Use of Prescription Drugs
dc.contributor | Aalto-yliopisto | fi |
dc.contributor | Aalto University | en |
dc.contributor.author | Böckerman, Petri | |
dc.contributor.author | Kortelainen, Mika | |
dc.contributor.author | Laine, Liisa T. | |
dc.contributor.author | Nurminen, Mikko | |
dc.contributor.author | Saxell, Tanja | |
dc.contributor.department | Department of Economics | en |
dc.contributor.organization | University of Jyväskylä | |
dc.contributor.organization | University of Turku | |
dc.contributor.organization | University of Missouri | |
dc.contributor.organization | Social Insurance Institution of Finland | |
dc.date.accessioned | 2025-02-24T21:39:48Z | |
dc.date.available | 2025-02-24T21:39:48Z | |
dc.date.issued | 2025-02 | |
dc.description.abstract | We estimate the effects of health information technology designed to improve access to medication while limiting overuse through easier prescription renewal and improved information provision. We focus on benzodiazepines, a commonly prescribed class of mental health and insomnia medications, which are highly effective but potentially addictive. We study the staggered rollout of a nationwide electronic prescribing system over four years in Finland and use population-wide, individual-level administrative data sets. We find that e-prescribing increases average benzodiazepine use due to increased prescription renewals. The increase is most pronounced for younger patients. E-prescribing can improve the health of elderly patients and may help to balance the access-overuse trade-off. Without additional monitoring for addiction in place, it may, however, also have unintended health consequences for younger patients, who are more likely to develop mental and behavioral health disorders. | en |
dc.description.version | Peer reviewed | en |
dc.format.mimetype | application/pdf | |
dc.identifier.citation | Böckerman, P, Kortelainen, M, Laine, L T, Nurminen, M & Saxell, T 2025, 'Information Technology, Improved Access, and Use of Prescription Drugs', Journal of the European Economic Association, vol. 23, no. 1, pp. 396-430. https://doi.org/10.1093/jeea/jvae034 | en |
dc.identifier.doi | 10.1093/jeea/jvae034 | |
dc.identifier.issn | 1542-4766 | |
dc.identifier.issn | 1542-4774 | |
dc.identifier.other | PURE UUID: c63544db-2a65-45ad-a26d-916a0e753f13 | |
dc.identifier.other | PURE ITEMURL: https://research.aalto.fi/en/publications/c63544db-2a65-45ad-a26d-916a0e753f13 | |
dc.identifier.other | PURE LINK: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=aalto_pure&SrcAuth=WosAPI&KeyUT=WOS:001283109800001&DestLinkType=FullRecord&DestApp=WOS_CPL | |
dc.identifier.other | PURE LINK: http://www.scopus.com/inward/record.url?scp=85217675859&partnerID=8YFLogxK | |
dc.identifier.other | PURE FILEURL: https://research.aalto.fi/files/173420678/BIZ_Information_Technology_Improved_Access_and_Use_of_Prescription_Drugs_jvae034_pdfa2b.pdf | |
dc.identifier.uri | https://aaltodoc.aalto.fi/handle/123456789/134279 | |
dc.identifier.urn | URN:NBN:fi:aalto-202502242549 | |
dc.language.iso | en | en |
dc.publisher | Oxford University Press | |
dc.relation.ispartofseries | Journal of the European Economic Association | en |
dc.relation.ispartofseries | Volume 23, issue 1, pp. 396-430 | en |
dc.rights | openAccess | en |
dc.rights | CC BY | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Information Technology, Improved Access, and Use of Prescription Drugs | en |
dc.type | A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä | fi |
dc.type.version | publishedVersion |